Table IV.
Presentations of BC patients treated in the DSO in groups A and B relating to the AJCC staging in the years 2007–2010
| Year | AJCC stage | Group A | Group B | P-value (χ2 test, one sided) (H0: A ≤ B) |
|---|---|---|---|---|
| 2007 | O + I II + III |
22 (43.1%) 29 (56.9%) |
42 (40.3%) 62 (59.6%) |
0.439 |
| 2008 | O + I II + III |
24 (58.6%) 17 (41.4%) |
36 (50.7%) 35 (49.3%) |
0.272 |
| 2009 | O + I II + III |
32 (53.3%) 28 (46.7%) |
48 (44.4%) 60 (55.6%) |
0.172 |
| 2010 | O + I II + III |
53 (66.2%) 27 (33.8%) |
56 (53.3%) 49 (46.7%) |
0.052 |
| 2007 + 2008 | O + I II + III |
46 (50%) 46 (50%) |
78 (44.6%) 97 (55.4%) |
0.237 |
| 2009 + 2010 | O + I II + III |
85 (60.7%) 55 (39.3%) |
104 (48.8%) 109 (51.2%) |
0.018 |
| Σ | O + I II + III |
131 (56.4%) 101 (43.6%) |
182 (46.9%) 206 (53.1%) |
0.013 |